Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Genetic polymorphism and asthma].

M Molimard1, R Marthan

  • 1Département de Pharmacologie, CHU Pellegrin-Carreire, Bordeaux. Mathieu.Molimard@pharmaco.u-bordeaux2.fr

Revue Des Maladies Respiratoires
|August 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Involvement of the Piezo1 and TRPV4 stretch-activated channels in pulmonary hypertension].

Revue des maladies respiratoires·2022
Same author

Methoxpropamine (MXPr) in powder, urine and hair samples: Analytical characterization and metabolite identification of a new threat.

Forensic science international·2022
Same author

[Introduction of an anticholinesterase drug in the context of myasthenia, in a severe asthmatic patient].

Revue des maladies respiratoires·2021
Same author

Effects of FW2 Nanoparticles Toxicity in a New In Vitro Pulmonary Vascular Cells Model Mimicking Endothelial Dysfunction.

Cardiovascular toxicology·2021
Same author

The determinants of dyspnoea evaluated by the mMRC scale: The French Palomb cohort.

Respiratory medicine and research·2020
Same author

Suitability of infrared spectroscopy for drug checking in harm reduction centres.

The International journal on drug policy·2020
Same journal

[French version of the guidelines for connective tissue disease-associated ILD].

Revue des maladies respiratoires·2026
Same journal

[Pulmonary expression of an asymptomatic lysosomal storage disorder].

Revue des maladies respiratoires·2026
Same journal

[Factors associated with FEV1 evolution in cystic fibrosis patients treated by CFTR modulator tritherapy].

Revue des maladies respiratoires·2026
Same journal

[Subacute pulmonary coccidioidomycosis: A differential diagnosis of lung cancer].

Revue des maladies respiratoires·2026
Same journal

[Relevance of the ACT score in severe asthma with obesity: A pilot study].

Revue des maladies respiratoires·2026
Same journal

[Automated analysis of mandibular movements for the screening of obstructive sleep apnea].

Revue des maladies respiratoires·2026
See all related articles

Genetic mutations in asthma pathophysiology are being studied, particularly in the beta 2 adrenergic receptor gene. While associations exist, a direct causal role for these mutations in asthma remains unconfirmed.

Area of Science:

  • Genetics and Molecular Biology
  • Pulmonology
  • Pharmacogenomics

Context:

  • Asthma pathophysiology involves complex genetic factors.
  • Mutations in genes related to asthma treatment are frequently observed.
  • The beta 2 adrenergic receptor is a key target for asthma pharmacotherapy.

Purpose:

  • To investigate the role of genetic mutations in asthma.
  • To explore the association between beta 2 adrenergic receptor gene mutations and asthma phenotypes.
  • To understand the impact of genetic polymorphisms on treatment response.

Summary:

  • Numerous mutations in genes relevant to asthma pathophysiology and treatment have been identified.
  • The beta 2 adrenergic receptor gene is a primary focus, with mutations potentially altering asthma phenotype and response to beta 2 agonists.

Related Experiment Videos

  • Polymorphisms in the beta 2 adrenoceptor gene are linked to variations in genes controlling its expression, necessitating consideration of linkage disequilibrium for accurate interpretation.

    • Impact:

    • Highlights the need for further research to establish causal links between genetic mutations and asthma.
    • Emphasizes the importance of personalized medicine approaches in asthma treatment based on genetic profiles.
    • Underscores the complexity of asthma genetics, involving gene-gene interactions and linkage disequilibrium.